ZoneOne Pharma was formed with the intent of developing rationally designed liposomal medicines for chronic disorders. Having developed a number of commercially successful FDA-approved liposomal drugs, our team knows how to match drugs with well-understood chemistry and biology to liposomal systems in order to develop therapies that meet a significant unmet clinical need. Our proprietary liposomal technologies and delivery systems offer superior dosing and compliance benefits over existing products. 

​